Aegon Ltd. (AEGOF) stock analysis
Close on Oct 19, 2026
StockData Score
Prices as of Oct 30, 2026How the score works
Weak0 of 30 checks passed
Aegon passes 0 of the 30 checks behind our score; 26 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 0/6
- Past performance
- 0/6
- Financial health
- 0/6
- Dividend
- 0/6
What stands out
Aegon passes none of the checks.
What to watch
Return on equity under 15%
Return on equity was 10.8% over the last twelve months and averaged 4.4% over five years; we look for 15% on both.
Return on assets under 1%
Return on assets was 0.3%; for a bank or insurer, 1% or more is considered good.
Return on equity below the industry
Aegon's return on equity of 10.8% is below the Life Insurance median of 11.7%.
No dividend
Aegon has not paid a dividend in the last twelve months.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S against the industry
Not enough revenue data to compare.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth0/6
Revenue growth over 3 years
Needs three years of positive revenue.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growth against the industry
Needs revenue for this year and last.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance0/6
Return on equity under 15%
Return on equity was 10.8% over the last twelve months and averaged 4.4% over five years; we look for 15% on both.
Return on assets under 1%
Return on assets was 0.3%; for a bank or insurer, 1% or more is considered good.
Return on equity below the industry
Aegon's return on equity of 10.8% is below the Life Insurance median of 11.7%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
Insurers do not split assets into current and non-current.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend0/6
No dividend
Aegon has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Aegon. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $54.42M
- Value traded per 1% price move
- $53.81M
Downside
Low risk
- Typical loss in a bad month
- 10.2%
- Volatility (annualized)
- 24%
- Sharpe ratio, 1 year
- 0.18
- Beta to the S&P 500 (5Y)
- 1.06
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2015 to 2025
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Net income | +42.0% | – | – | – | |
| Free cash flow | -44.7% | -46.7% | – | -7.1% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -0.6% | 10.5% | |
| Return on assets | – | -0.0% | 0.3% | |
| Debt to equity | 0.54 | 0.35 | – | |
| Net debt to EBITDA | – | 0.01× | – | |
| Capex to revenue | 0.2% | 0.4% | – | |
| Diluted shares | 2.05B | 2.04B | 1.55B |
Where the cash went
Fiscal 2021 to 2025, five years combined
Aegon generated €6.53B from operations and spent €4.75B on capital expenditure, dividends and share buybacks. 6% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2022 | -2.7% | 0.05× | 34.81× | -4.7% |
| FY2021 | 9.4% | 0.05× | 23.79× | 10.4% |
| FY2020 | -0.7% | 0.05× | 18.03× | -0.6% |
| FY2019 | 4.4% | 0.07× | 17.73× | 5.3% |
| FY2018 | 2.4% | 0.07× | 16.92× | 3.0% |
| FY2017 | 7.5% | 0.08× | 16.98× | 10.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero€977.00M
- Cash generatingOperating cash flow above zero€434.00M
- Return on assets improvedROA up on the prior year0.2% → 0.3%
- Earnings backed by cashOperating cash flow above net income€434.00M vs €977.00M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise1.63B → 1.55B
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose– → –